Recon: Lawmakers ask FTC for PBM merger review

Regulatory Focus-16 hours ago

Meet the Rebate, the New Villain of High Drug Prices (NYT); Amgen Loses ... Compounded Products Within Expiry Due to Lack of Sterility Concerns (FDA)